Skip to content

Buy Krsnaa Diagnostics; target of Rs 868: Khambatta Securities

Khambatta Securities is bullish on Krsnaa Diagnostics has recommended buy rating on the stock with a target price of Rs 868 in its research report dated September 02, 2022.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish